drugset / Trial / NCT01789216

Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)

NCT01789216

Phase 3 Completed 450 enrolled Major Extremity Trauma Research Consortium
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to definitively resolve questions regarding the use of multimodal pharmacologic pain management for orthopedic trauma patients in the context of a multicenter, randomized clinical trial. Also, as a significant proportion of this population develops chronic post traumatic osteoarthritis (PTOA), a sub-objective of this study is to examine the etiology and incidence of chronic pain and PTOA in this population.

Timeline

Start
2013-07
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 30 mg Intravenous
Comparator Meloxicam Small molecule
Comparator Pregabalin Small molecule 75 mg Oral

Indications

No indication recorded.